Chi Sheng Chemical (4111) - Total Assets
Based on the latest financial reports, Chi Sheng Chemical (4111) holds total assets worth NT$1.84 Billion TWD (≈ $58.01 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Chi Sheng Chemical - Total Assets Trend (2017–2024)
This chart illustrates how Chi Sheng Chemical's total assets have evolved over time, based on quarterly financial data. Also see Chi Sheng Chemical market capitalisation for the company's overall valuation and market capitalisation.
Chi Sheng Chemical - Asset Composition Analysis
Current Asset Composition (December 2024)
Chi Sheng Chemical's total assets of NT$1.84 Billion consist of 44.8% current assets and 55.2% non-current assets. Review 4111 liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 19.2% |
| Accounts Receivable | NT$302.97 Million | 17.3% |
| Inventory | NT$96.85 Million | 5.5% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Chi Sheng Chemical's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Chi Sheng Chemical stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Chi Sheng Chemical's current assets represent 44.8% of total assets in 2024, an increase from 39.2% in 2017.
- Cash Position: Cash and equivalents constituted 19.2% of total assets in 2024, up from 13.9% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 17.3% of total assets.
Chi Sheng Chemical Competitors by Total Assets
Key competitors of Chi Sheng Chemical based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Autek China Inc
SHE:300595
|
China | CN¥6.40 Billion |
|
Jiangxi Sanxin Medtec Co Ltd
SHE:300453
|
China | CN¥2.44 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
|
Dentium
KO:145720
|
Korea | ₩932.79 Billion |
|
Interojo Inc
KQ:119610
|
Korea | ₩252.22 Billion |
Chi Sheng Chemical - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.84 | 1.70 | 2.33 |
| Quick Ratio | 1.63 | 1.52 | 2.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$381.42 Million | NT$334.94 Million | NT$362.25 Million |
Chi Sheng Chemical - Advanced Valuation Insights
This section examines the relationship between Chi Sheng Chemical's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.43 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -0.9% |
| Total Assets | NT$1.75 Billion |
| Market Capitalization | $54.10 Million USD |
Valuation Analysis
Below Book Valuation: The market values Chi Sheng Chemical's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Chi Sheng Chemical's assets decreased by 0.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Chi Sheng Chemical (2017–2024)
The table below shows the annual total assets of Chi Sheng Chemical from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$1.75 Billion ≈ $55.12 Million |
-0.93% |
| 2023-12-31 | NT$1.77 Billion ≈ $55.64 Million |
-1.91% |
| 2022-12-31 | NT$1.80 Billion ≈ $56.73 Million |
+8.48% |
| 2021-12-31 | NT$1.66 Billion ≈ $52.29 Million |
+11.64% |
| 2020-12-31 | NT$1.49 Billion ≈ $46.84 Million |
-2.32% |
| 2019-12-31 | NT$1.52 Billion ≈ $47.95 Million |
+1.24% |
| 2018-12-31 | NT$1.50 Billion ≈ $47.36 Million |
+1.45% |
| 2017-12-31 | NT$1.48 Billion ≈ $46.69 Million |
-- |
About Chi Sheng Chemical
Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic … Read more